NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity RFA-OD-22-004 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for Tobacco Centers of Regulatory Science (TCORS) to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the Research Objectives related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP).
Notice NOT-OD-22-088 from the NIH Guide for Grants and Contracts
Notice NOT-NR-22-013 from the NIH Guide for Grants and Contracts
Notice NOT-HD-22-005 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-077 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-22-115 from the NIH Guide for Grants and Contracts. Violence affects people of all ages and its impact is far-reaching. It is a leading cause of death and nonfatal injuries in the United States and constitutes a major public health crisis, especially among young people, and in particular among racial/ethnic minority, sexual and gender minority (SGM) and disability populations. Firearm homicide is the third leading cause of death among persons aged 10 to 24 years and the leading cause of death among Black men (45 years of age). NIH is committed to supporting research that identifies innovative prevention approaches to reduce firearm and related violence, injury and mortality. Within the legislative mandates and limitations of NIH funding (NOT-OD-21-058, NOT-OD-21-056), this initiative will support a network of research projects to develop and test interventions at the community or community organization level that aim to prevent firearm and related violence, injury and mortality.This FOA solicits bi-phasic research projects proposed in UG3/UH3 Phased Innovation Awards Cooperative Agreement applications. Funding for the UG3 phase (phase I) will be used to demonstrate sufficient preparation, feasibility and capacity to meet foundational milestone targets specific to the work proposed. A UG3 project that meets its milestones will be administratively considered by NIH and prioritized for transition to the UH3 award phase II). Applicants responding to this FOA must address specific aims and milestones for both the UG3 and UH3 phases.
Funding Opportunity PAR-22-120 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to seek applications for a Coordinating Center (CC) for Community-Level Interventions for Firearm Violence Prevention (CLIF-VP) Research Network. Members of the CLIF-VP Research Network, including the CC, will work collaboratively with the NIH to develop and test interventions at the community or community organization level that aim to prevent firearm and related violence, injury, and mortality. The CLIF-VP Research Network will include the CC funded under this Cooperative Agreement FOA (XXX-XX-XX-XXX) and up to 10 Research Projects funded under the companion UG3/UH3 Phased Cooperative Agreement FOA, Research on Community Level Interventions to Prevent Firearm and Related Violence, Injury, and Mortality (XXX-XX-XX-XXX. In phase 1 (1-2 years) the Research Projects will need to demonstrate sufficient preparation, feasibility, and capacity for the planned intervention study. Those that pass their milestones will transition into phase 2, during which they will implement their proposed intervention. The CC will provide overarching support and guidance to the network in three domains: (1) administration, coordination, and communication; (2) data, measurement, and analytic support and consultation; and (3) public/stakeholder engagement and dissemination support. It is important that applicants for the CC also read the companion FOA to understand the full mission and structure of the research network.
Notice NOT-DK-22-016 from the NIH Guide for Grants and Contracts
Notice NOT-MD-22-013 from the NIH Guide for Grants and Contracts
Notice NOT-HL-22-014 from the NIH Guide for Grants and Contracts
Notice NOT-GM-22-031 from the NIH Guide for Grants and Contracts
Notice NOT-AI-22-040 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DE-23-002 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support interdisciplinary research to better understand the underlying mechanisms and interplay of biological, psychosocial, behavioral, and social structural factors contributing to oral health, mental health and co-occurring disorders in people living with HIV.
Funding Opportunity RFA-DE-23-003 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support interdisciplinary research to better understand the underlying mechanisms and interplay of biological, psychosocial, behavioral, and social structural factors contributing to oral health, mental health and co-occurring disorders in people living with HIV.
Notice NOT-HL-22-011 from the NIH Guide for Grants and Contracts
Notice NOT-CA-22-036 from the NIH Guide for Grants and Contracts
Notice NOT-AI-22-035 from the NIH Guide for Grants and Contracts
Notice NOT-CA-22-060 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DK-21-505 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for a Data Coordinating Center (DCC) that will support the Diabetic Foot Consortium (DFC) for clinical research on diabetic foot ulcers. The first studies will validate biomarkers that predict healing or response to therapy and assess infection or recurrence risk. Future research may involve clinical trials and studies on the pathophysiology of diabetic foot ulcers. Given the clinical complexity of diabetic wound healing, the applicant must have experience serving as the DCC on clinical studies of diabetic foot ulcers. The DCC will provide overall project coordination, administration, quality control, data management, and biostatistical support.
Funding Opportunity RFA-AI-22-016 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the development of new diagnostic technologies for tuberculosis (TB) drug susceptibility testing (DST), including point of care (POC) DST and companion diagnostics for new TB drugs.